CogniFit and Eurofins Optimed advance digital cognitive assessment in early clinical research. Image by CogniFitCogniFit, a global leader in digital cognitive assessment technologies for clinical research, today announced a new collaboration with Eurofins Optimed, a leading early-phase Contract Research Organization (CRO) within the Eurofins network of companies, to support an ongoing clinical research study.The collaboration brings together Eurofins Optimed’s extensive expertise in early clinical development with CogniFit’s scientifically validated digital cognitive assessment platform, further advancing the integration of innovative digital endpoints into modern clinical trials.With more than 35 years of experience, Eurofins Optimed is recognized as a trusted partner for pharmaceutical, biotechnology, medtech and nutrition companies. Specializing in First-in-Human (FIH), Phase I and early Phase II studies, the organization provides fully integrated clinical development services, from protocol design and regulatory strategy through clinical operations, bioanalysis, biometrics and study reporting, supported by its dedicated Clinical Trials Unit in France and an international network of investigators.As part of the collaboration, Eurofins Optimed is utilizing CogniFit’s digital cognitive assessment platform within an ongoing clinical research study. CogniFit’s technology delivers sensitive, rapid and standardized measurements of cognitive performance, supporting researchers with reliable cognitive endpoints, longitudinal monitoring and scalable digital assessments across clinical development programs.“We are proud to collaborate with Eurofins Optimed, a recognized leader in early clinical development,” said Marcos Val, Chief Business Officer at CogniFit. “Clinical research is increasingly embracing digital technologies that improve data quality, operational efficiency and patient experience. We believe this collaboration demonstrates the growing importance of scientifically validated digital cognitive assessments in supporting modern clinical research.”The collaboration represents another milestone in CogniFit’s expansion within the clinical research ecosystem, where pharmaceutical companies, biotechnology organizations, academic researchers and CROs increasingly require sensitive, scalable and remotely deployable cognitive assessments to support study design and decision-making.CogniFit’s Clinical Trials platform currently supports researchers through:Scientifically validated digital cognitive assessmentsElectronic Clinical Outcome Assessments (eCOA)Custom cognitive assessment protocolsScientific consultingLongitudinal cognitive monitoringRemote and decentralized cognitive assessment capabilitiesThese capabilities help optimize participant selection, monitor cognitive change over time and generate reliable cognitive data throughout the clinical development lifecycle.While details of the ongoing study remain confidential, the collaboration reflects CogniFit’s commitment to supporting innovation in early clinical development through scientifically validated digital technologies.About Eurofins OptimedEurofins Optimed is a leading Contract Research Organization specializing in early clinical development and part of the Eurofins network of companies, one of the world’s leading providers of laboratory testing and scientific services.With over 35 years of experience, Eurofins Optimed supports pharmaceutical, biotechnology, medtech and nutrition companies through integrated early clinical development solutions including protocol design, regulatory affairs, First-in-Human studies, Phase I and early Phase II clinical trials, project management, biometrics, bioanalysis and medical writing. Its quality-driven approach, dedicated Clinical Trials Unit and international network help sponsors accelerate innovative therapies from concept to proof of clinical value. Website: www.eurofins-optimed.comAbout CogniFitCogniFit is a global digital brain health platform providing scientifically validated cognitive assessment and training solutions for healthcare providers, researchers, employers, insurers and clinical research organizations.Its Clinical Trials platform supports sponsors and investigators with digital cognitive endpoints, eCOA, custom assessment protocols, scientific consulting and remote cognitive monitoring. CogniFit’s technology is currently used by more than 1,000 clinical studies and research institutions worldwide, helping researchers generate reliable, standardized cognitive data across multiple therapeutic areas. Website: www.cognifit.com/clinical-trialsThe post CogniFit Supports Eurofins Optimed in Advancing Digital Cognitive Assessment in Early Clinical Research appeared first on CogniFit Blog: Brain Health News.